Elliot Cooperstone Sells 41,357 Shares of Cano Health, Inc. (NYSE:CANO) Stock

Cano Health, Inc. (NYSE:CANOGet Free Report) major shareholder Elliot Cooperstone sold 41,357 shares of Cano Health stock in a transaction that occurred on Monday, January 29th. The stock was sold at an average price of $2.74, for a total transaction of $113,318.18. Following the completion of the sale, the insider now owns 538,745 shares of the company’s stock, valued at $1,476,161.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Major shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Elliot Cooperstone also recently made the following trade(s):

  • On Friday, January 26th, Elliot Cooperstone sold 32,693 shares of Cano Health stock. The stock was sold at an average price of $2.74, for a total transaction of $89,578.82.
  • On Wednesday, January 24th, Elliot Cooperstone sold 35,808 shares of Cano Health stock. The stock was sold at an average price of $2.84, for a total transaction of $101,694.72.
  • On Monday, January 22nd, Elliot Cooperstone sold 125,000 shares of Cano Health stock. The shares were sold at an average price of $2.50, for a total transaction of $312,500.00.
  • On Wednesday, January 17th, Elliot Cooperstone sold 100,000 shares of Cano Health stock. The shares were sold at an average price of $2.32, for a total transaction of $232,000.00.
  • On Friday, January 12th, Elliot Cooperstone sold 24,171 shares of Cano Health stock. The stock was sold at an average price of $3.30, for a total transaction of $79,764.30.
  • On Wednesday, January 10th, Elliot Cooperstone sold 25,000 shares of Cano Health stock. The stock was sold at an average price of $3.73, for a total transaction of $93,250.00.
  • On Monday, January 8th, Elliot Cooperstone sold 25,000 shares of Cano Health stock. The stock was sold at an average price of $3.82, for a total transaction of $95,500.00.
  • On Thursday, January 4th, Elliot Cooperstone sold 13,328 shares of Cano Health stock. The shares were sold at an average price of $4.00, for a total transaction of $53,312.00.
  • On Tuesday, January 2nd, Elliot Cooperstone sold 43,505 shares of Cano Health stock. The stock was sold at an average price of $5.42, for a total transaction of $235,797.10.
  • On Thursday, December 28th, Elliot Cooperstone sold 41,197 shares of Cano Health stock. The stock was sold at an average price of $6.00, for a total transaction of $247,182.00.

Cano Health Price Performance

Shares of NYSE CANO opened at $2.69 on Wednesday. The stock has a market capitalization of $14.55 million, a price-to-earnings ratio of -0.01 and a beta of 0.07. Cano Health, Inc. has a 12 month low of $1.74 and a 12 month high of $190.00. The firm’s 50 day simple moving average is $5.79 and its 200-day simple moving average is $3.13. The company has a debt-to-equity ratio of 3.95, a current ratio of 0.40 and a quick ratio of 0.40.

Cano Health (NYSE:CANOGet Free Report) last announced its earnings results on Thursday, November 9th. The company reported ($91.87) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($18.50) by ($73.37). The business had revenue of $788.07 million for the quarter, compared to analysts’ expectations of $757.20 million. Cano Health had a negative net margin of 18.62% and a negative return on equity of 133.59%. Analysts expect that Cano Health, Inc. will post -2.01 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of the stock. Goldman Sachs Group Inc. increased its position in shares of Cano Health by 133.8% during the 2nd quarter. Goldman Sachs Group Inc. now owns 5,504,486 shares of the company’s stock worth $24,109,000 after purchasing an additional 3,149,952 shares during the last quarter. Armistice Capital LLC purchased a new position in shares of Cano Health in the 4th quarter valued at about $3,661,000. Norges Bank purchased a new position in shares of Cano Health in the 4th quarter valued at about $3,620,000. State Street Corp lifted its stake in Cano Health by 215.1% during the second quarter. State Street Corp now owns 3,359,294 shares of the company’s stock worth $14,714,000 after purchasing an additional 2,293,310 shares during the last quarter. Finally, Point72 Asset Management L.P. lifted its stake in Cano Health by 52.5% during the second quarter. Point72 Asset Management L.P. now owns 6,558,600 shares of the company’s stock worth $9,116,000 after purchasing an additional 2,258,700 shares during the last quarter. Hedge funds and other institutional investors own 35.99% of the company’s stock.

Analyst Ratings Changes

Separately, UBS Group reissued a “sell” rating and set a $3.75 price target (down from $12.00) on shares of Cano Health in a research report on Friday, November 17th.

View Our Latest Research Report on CANO

Cano Health Company Profile

(Get Free Report)

Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.

See Also

Insider Buying and Selling by Quarter for Cano Health (NYSE:CANO)

Receive News & Ratings for Cano Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cano Health and related companies with MarketBeat.com's FREE daily email newsletter.